Trademark: 79361574
Word
AKRIBION
Status
Pending
Status Code
686
Status Date
Tuesday, February 27, 2024
Serial Number
79361574
Mark Type
4000
Filing Date
Wednesday, October 26, 2022
Published for Opposition
Tuesday, February 27, 2024

Trademark Owner History
BRAIN Biotech AG - Owner At Publication

Classifications
40 Recycling of waste and trash; air purification and treatment of water; food and drink preservation; processing of biological materials, namely, batch biological treatment services; waste treatment; joining of materials or substances, namely, custom additive manufacturing for others; treatment of hazardous substances, namely, waste, gases and liquids; treatment of materials using biotechnological method, namely, bio-hazard biological decontamination services
44 Medical services based on biotechnological methods; veterinary services based on biotechnological methods; hygienic and beauty care for human beings and animals based on biotechnological methods; agriculture, horticulture and forestry services, namely, cultivation of agricultural plants for others, horticultural services, and forest habitat restoration, all based on biotechnological methods; regenerative medicine services; medical analysis services for diagnostic and treatment purposes by medical laboratories; medical treatment with cultured cells; medical screening; animal breeding; DNA screening for medical purposes; conducting medical analysis by a medical laboratory for the purpose of the treatment of persons; health care for people; medical analysis services relating to the treatment of persons; medical analysis for the diagnosis and treatment of persons; medical diagnostic testing and analysis services; medical services; medical services in the field of diabetes; medical and health care services; medical and health care services relating to DNA, genetics and genetic testing; medical services for the treatment of the skin; medical services for the treatment of diseases of the human body; medical care and analysis services relating to the treatment of patients; providing information relating to medical services
42 Testing of materials; quality control for others; biological analysis; biological research; biological laboratory services; biological research and analysis; biological research; clinical research in the field of pharmaceuticals and medical research; research services, namely, scientific research; provision of research services, namely, product research; biomedical research services; industrial research in the field of pharmaceuticals; medical research; pharmaceutical research services; genetic research; research relating to biotechnology; providing information relating to scientific research in the fields of biochemistry and biotechnology; scientific research; technical research, namely, biochemistry research services, biotechnology research services, Research in the field of DNA repair technology, RNA interference technology research, Research in the field of gene editing technology ; chemical research and analysis services; medical, biopharmaceutical and biotechnological research laboratories; research and development of new products for others; computer aided scientific research services; computer aided industrial research services in the field of pharmaceuticals, biotechnology and medicine; biochemical research and analysis; scientific research relating to biology; biotechnological research; biotechnological research relating to industry; scientific and industrial research in the field of gene editing technology, RNA interference technology, DNA repair technology, pharmaceuticals, biotechnology and medicine; scientific research for medical purposes; industrial analysis and research services in the field of gene editing technology, RNA interference technology, DNA repair technology, pharmaceuticals, biotechnology and medicine; medical and pharmacological research services; biological research laboratory services; chemical research laboratory services; chemical research; pharmaceutical research and development; DNA screening for scientific research purposes; research to develop new products; research in the field of gene therapy; cell separation research services; biochemical research and development; research in the field of science provided by engineers; research and development services in the field of chemistry; scientific services, namely scientific investigations for medical and pharmaceutical purposes and medical research relating thereto; scientific research relating to genetics; research and development in the pharmaceutical and biotechnology fields; preparation of biological samples for analysis in research laboratories; research and development in the field of diagnostic preparations; research and development in the field of biotechnology; consultancy in the field of industrial research relating to pharmaceuticals; consultancy in the field of scientific research; analysis of human tissues for medical research; preparation of biological samples for testing and analysis in research laboratories; research and development in the field of microorganisms and cells; biochemical analysis; scientific analysis in the field of biochemistry and biotechnology; technological analysis services, namely technological analysis of gene editing technology, RNA interference technology, DNA repair technology; chemical analysis; scientific research and analysis in the field of biochemistry; analysis in the field of molecular biology; scientific research in the field of genetics; genetic engineering; molecular biology research; scientific research in the field of DNA modification; industrial research in the field of DNA modification ; pharmaceutical research in the field of DNA modification; veterinary research in the field of DNA modification; medical research in the field of DNA modification; veterinary pharmaceutical research in the field of DNA modification; biological testing of materials; biochemical engineering services; biotechnological research relating to agriculture; biotechnological research relating to livestock; analysis services relating to the testing of chemical ingredients in liquids; analysis services relating to the determination of bacterial content in liquids; analysis services relating to the detection of bacterial content in liquids; bacteriological analysis; bacteriological research and analysis; bacteriological research and testing; advice on research in the field of pharmacogenetics; advice on pharmaceutical research and development; consultancy in the field of bacteriological research; consultancy services relating to technological research of gene editing technology, RNA interference technology, DNA repair technology, pharmaceuticals, biotechnology and medicine; consultancy services relating to scientific research; biochemical analysis; biochemical research service; biotechnical research in the industrial sector, namely, biotechnical research in the field of pharmaceuticals; computer-aided industrial analysis services in the field of pharmaceuticals; computer-aided scientific analysis in the field of pharmaceuticals; medical research laboratory services; medical laboratory services; DNA verification for scientific research purposes; conducting chemical research; research in the field of biotechnology; research in the field of medicine; research in the medical field; research on biotechnology; research on chemistry; research and development in the field of bacteriology; research and testing in the fields of bacteriology and virology; research and development services for the pharmaceutical industry; research and development services in the field of biotechnology; research and development services in the field of microorganisms and cells; research work of engineers in the technological field, namely, research in the field of genetic engineering; scientific research work by engineers; research for the development of new products; medical research services; pharmaceutical research; pharmaceutical development; technical research services, namely, product research; scientific services, namely, scientific laboratory services and related scientific research; scientific research in the field of bacteriology; scientific research in the field of pharmacy; scientific research in biology; scientific research in the field of genetics and genetic engineering; scientific research and development of new products for others; scientific research using databases; scientific research services; scientific and technological services, namely, scientific laboratory and software development in the fields of medicine, medical technology, biotechnology, biology, biochemistry and chemistry; research and design of new products in the fields of medicine, medical technology, biotechnology, biology, biochemistry and chemistry; industrial analysis and research services in the field of medicine, medical technology, biotechnology, biology, biochemistry and chemistry; design and development of computer software for use in the field of medicine, medical technology, biotechnology, biology, biochemistry and chemistry; consultancy and information in relation to the aforesaid services

Trademark Events
Feb 27, 2024
Notification Processed By Ib
Feb 27, 2024
Published For Opposition
Feb 7, 2024
Notification Of Possible Opposition Sent To Ib
Feb 7, 2024
Notification Of Notice Of Publication E-Mailed
Feb 7, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 7, 2024
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 18, 2024
Approved For Pub - Principal Register
Jan 16, 2024
Teas/Email Correspondence Entered
Jan 16, 2024
Correspondence Received In Law Office
Jan 16, 2024
Teas Request For Reconsideration Received
Dec 20, 2023
Notification Of Final Refusal Emailed
Dec 20, 2023
Final Refusal E-Mailed
Dec 20, 2023
Final Refusal Written
Nov 22, 2023
Teas/Email Correspondence Entered
Nov 22, 2023
Correspondence Received In Law Office
Nov 22, 2023
Teas Response To Office Action Received
Oct 4, 2023
Refusal Processed By Ib
Sep 11, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Sep 11, 2023
Refusal Processed By Mpu
Aug 19, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Aug 18, 2023
Non-Final Action Written
Aug 10, 2023
Assigned To Examiner
Feb 13, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 13, 2023
Teas Change Of Correspondence Received
Feb 13, 2023
Teas Change Of Domestic Representatives Address
Feb 13, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 13, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 13, 2023
Teas Change Of Owner Address Received
Feb 7, 2023
Application Filing Receipt Mailed
Feb 3, 2023
New Application Office Supplied Data Entered
Feb 2, 2023
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24